---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-064437"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:24:07.988967+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Haemonetics prices $600M 2.50% convertible notes due 2029; to repurchase $200M of 2026 notes

## Summary
- $600M 2.50% convertible senior notes due 2029 priced; initial conversion price ~$117.12/share (30% premium over $90.09 closing).
- Concurrently repurchasing $200M aggregate principal of 0.00% 2026 notes for $185.5M cash in privately negotiated transactions.
- Net proceeds estimated ~$584.8M; to repay $230M revolver, pay ~$75.6M for capped calls, and for general purposes.
- Capped call transactions entered to offset dilution, with initial cap price $180.18/share (~100% premium).
- Initial purchasers granted option to buy up to additional $100M principal amount of notes.

## SEC filing metadata
- accession: 0001104659-24-064437
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000110465924064437/0001104659-24-064437-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000110465924064437/tm2415391d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-064437
- JSON: https://secwatch.observer/filing/0001104659-24-064437.json
- Plain text: https://secwatch.observer/filing/0001104659-24-064437.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.